Armistice Capital Master Fund Ltd. - Insider Non-Derivative Transactions at Avalo Therapeutics, Inc. (AVTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 27, 2023, Armistice Capital Master Fund Ltd.'s relationship to Avalo Therapeutics, Inc. (AVTX) is TenPercentOwner, and currently has 731,458 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AVTX insiders.
Data Source: SEC.
Armistice Capital Master Fund Ltd. - Insider Non-Derivative Transactions of AVTX Common Stock
Armistice Capital Master Fund Ltd. - Insider Non-Derivative Transactions at AVTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 28, 2023 | Sell -- (Common Stock) | 937404 | 0.52 | 731458 |
| Jun 27, 2023 | Sell -- (Common Stock) | 2746138 | 0.61 | 1668862 |